Relatlimab
Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer[1].
Product Specifications
CAS Number
1673516-98-7
Product Name Alternative
BMS-986016
UNSPSC
12352203
Target
LAG-3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/relatlimab.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
[Relatlimab]
Molecular Weight
(145.58 kDa)
References & Citations
[1]Thudium K, et, al. Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab. Cancer Immunol Res. 2022 Aug 18:CIR-22-0057.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400633-500 1x 500 µL
Von Willebrand Factor (3E2D10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![Suppressor of Ty 4 homolog 1 (SUPT4H1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI5F12]](https://cdn.genprice.uk/products/937/6868c3bb994c49e6dc3fd38b/imageurl/ta803431am.webp)
TA803431AM 100 µL
Suppressor of Ty 4 homolog 1 (SUPT4H1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI5F12]
Sign In for Pricing
View Details